OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Molecular imaging using positron emission tomography (PET) has become a major biomedical imaging technology. Its application towards characterisation of biochemical processes in disease could enable early detection and diagnosis, development of novel therapies and treatment evaluation. The technology is underpinned by the use of chemical probes radiolabelled with short-lived positron-emitting radioisotopes which can be designed to be specific and selective for biological targets in vivo e.g., receptors, protein deposits, enzymes, and metabolism. My talk will focus on their development, the translational steps, and their application to clinical PET imaging research into neurodegenerative diseases to delineate and understand the various pathological components of these disorders.
